Recruiting

Observational Study

Sponsor:

Ohio State University

Code:

NCT03146676

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Study Details

Brief summary:

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Conditions

Hidradenitis Suppurativa

Study ID

NCT03146676

Start date

Apr 19, 2017

Status verified date

Feb, 2026

Completion date

Dec 31, 2030

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
  • Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
  • Willingness to participate in a research study.

Exclusion Criteria:

  • Inability to provide informed consent

Study Design

Enrollment

175 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Alison Rocchi

614-685-0251alison.wandling@osumc.edu

Kristina Susi

614-814-1277Kristina.Susi@osumc.edu

Locations

OSU Dermatology West

Recruiting

Columbus, Ohio, United States, 43215

Contacts

Alison Rocchi

614-685-0251Alison.Wandling@osumc.edu

Kristina Susi

614-814-1277Kristina.Susi@osumc.edu

Principal Investigator:

Benjamin Kaffenberger, MD

More Information

Sponsor

Ohio State University

Last update posted

Feb 27, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ohio State University on 2026-02-27.